Advanced Drug Delivery Technologies
Enabling Drug Reformulations and Administration Routes
Exciting developments are occurring in the field of alternative drug delivery—a phrase that describes the reformulation of drugs to enable lower doses, more convenient delivery routes, and supplemental therapeutic indications.... |
Novel Targets in Drug Discovery
In recent years, the process of drug discovery has changed immeasurably. It
has gone from a process that was largely disease-focused to one that is
target-led. This change has been driven by... |
Global Markets for Assisted Reproductive Devices
2009
Global Markets for Assisted Reproduction covers the U.S., 15 Countries in Europe and Japan. This report includes the Oocyte Retrieval Needle Market, Embryo Transfer Catheter Market and the Reproductive Media... |
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018
Future Therapies for Birth Control and Reproductive Health
In this report, The Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health (2nd Edition) the reader will be introduced to... |
Biosimilars
2009 - 2014
The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars... |
Drug Treatments for Leading Endocrine and Metabolic Diseases
The aim of this report is to provide a range of information - from detailed market analyses through industry trends - to quantify, qualify, and compare prescription products on the... |
Stakeholder Insight: Infertility
Undifferentiated drugs force need to strengthen prescriber and payer relationship
Introduction
Over 11.5 million women suffer from infertility in the seven major markets. Although prevalence rates are stable, the trend towards later parenthood is inducing an increasing demand for infertility treatments.... |
Thrombopoiesis-Stimulating Agents (TPO)
Competitor Analysis
The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO; IL-11) as of January 2011 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and... |
Biologic Imaging Reagents: Technologies and Global Markets
This report:
Describes various imaging reagent types including optical probes and dyes, imaging nanomaterials, supermolecules, contrast agents and radiopharmaceuticals
Provides market forecasts to determine the global market and future demand growth for... |
Therapeutic Protein Pipeline Database
1-Year Subscription
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each... |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
Report overview
The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness. New... |
Global Protein Therapeutics Market, The
Market Dynamics and Pipeline Analysis
The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products... |
Therapeutics and Diagnostics for Women's Disorders
Study Goals and Objectives
This BCC Research report, Therapeutics and Diagnostics for Women's Disorders, provides an overview of products included in this market, and detailed analyses of markets and competitive environments.... |
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics
This Report:
Discussion of Treatment Options, Key Products and New Developments in Therapies for Such Genetic Disorders as Cystic Fibrosis, Gaucher Disease, Hemophilia, Huntington' S Disease, Sickle-Cell Disease, and Tay-Sachs Disease
Analysis... |
The Future of the Biologicals Market
Market overview, innovations and company profiles
Biopharmaceutical products are the key to the future of the pharmaceutical market. Even before the market stagnation seen in 2009 due to the recession, conventional pharmaceuticals were facing drastic consequences... |
Japanese Market for Women's Health Devices
2009
In 2008, the Japanese market for women's health devices was valued at over $234 million. Over 40% of the Japanese market for women's health devices was accounted for by OB/GYN... |
Biosimilars: Surveying the Market Landscape
Worldwide, the story is the same. Governments want cheaper drugs for their populations, while the number and kinds of diseases affecting them continue to evolve and grow.
Since 1976, when Genentech... |
Global Markets for Orphan Drugs
This Report Contains
An Overview of Orphan Drug Criteria, The History of The Orphan Drug Act and Its Influence and Advantages Inherent in Orphan Drug Designation
Global Market Projections, with Data for... |
U.S. Preimplantation Genetic Diagnosis Market
This research service analyzes the market for the preimplantation genetic diagnosis (PGD) market. Key market drivers and restraints are ranked and discussed. PGD revenue forecasts are modeled largely on annual... |
Women's Reproductive Disorders Therapeutics 2008-2018
Visiongain predicts that there is great potential for the women's reproductive disorders therapeutics market from present onwards, as this new report Women's Reproductive Disorders Therapeutics, 2008-2018 shows.
Oral Contraceptive Market The... |
Antibody Technology Companies 2010
A systematic guide through the landscape of antibody technologies and their providers
The report "Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers" provides a description and assessment of antibody technologies and their corporate... |
New Therapeutics and Diagnostics for Women’s Disorders
Women's disorders involve many different areas. The most obvious covered under this broad title are those dealing with reproduction, menstruation, cancer, pregnancy and menopause. However, these are far from the... |
Cytology and HPV Testing World Markets
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by... |
European Markets for Women's Health Devices (15 Countries)
Executive Summary for Report
This product is the Executive Summary for the above report. The abstract and contents relate to the report itself.
Abstract
In 2008, the market for women's health devices in Europe was valued... |
European Markets for Women's Health Devices (15 Countries)
In 2008, the market for women's health devices in Europe was valued at 563 million euros. More than 30% of this value was accounted for by OB/GYN ultrasound imaging alone.This... |
Antiageing and Life Enhancement Pharmacotherapeutics
Facets of normal chronological ageing and lifestyle contribute to a diverse group of highly prevalent conditions that are associated with physiological or psychological deficits or symptoms of sufficient severity which... |
How Drugs Are Developed
3rd Edition
Reimbursement mechanisms for medical technology are highly complex in most countries, with different systems applicable to private and public healthcare, to different product categories and even to different regions of... |
